Article
Prognostic impact of INK4A deletion in Ewing sarcoma
15 Aug 2000
Abstract excerpt
BACKGROUND: The primary genetic alteration in > 95% of Ewing sarcomas (ES) is a specific fusion of EWS with FLI1 or ERG. Secondary genetic alterations possibly involved in progression of ES are not well understood. A recent study found loss of the negative cell cycle regulator gene INK4A in 8 of 27 ES samples (30%). To confirm these findings and evaluate their prognostic significance, the authors studied INK4A...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
